Coassociation of ERα and p160 proteins predicts resistance to endocrine treatment; SRC-1 is an independent predictor of breast cancer recurrence

被引：0
|
作者：
Redmond, A. M. [1 ]
Bane, F. T. [1 ]
Stafford, A. T. [1 ]
McIlroy [1 ]
Dillon, M. F. [1 ]
Hill, A. D. K. [1 ]
Young, L. S. [1 ]
机构：
[1] Royal Coll Surgeons Ireland, Dublin 2, Ireland
来源：
CANCER RESEARCH | 2009年 / 69卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：214S / 214S
页数：1
相关论文
共 23 条
  • [1] Coassociation of Estrogen Receptor and p160 Proteins Predicts Resistance to Endocrine Treatment; SRC-1 is an Independent Predictor of Breast Cancer Recurrence
    Redmond, Aisling M.
    Bane, Fiona T.
    Stafford, T.
    Mcllroy, Marie
    Dillon, Mary F.
    Crotty, Thomas B.
    Hill, Arnold D.
    Young, Leonie S.
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (06) : 2098 - 2106
  • [2] The Interaction of High Mobility Group Proteins with the p160 Coactivator SRC-1; a Role in Endocrine Resistance.
    Redmond, A. M.
    Stafford, A. T.
    McIlroy, M.
    Hill, A. D. K.
    Young, L. S.
    [J]. CANCER RESEARCH, 2009, 69 (24) : 811S - 811S
  • [3] SRC-1 expression is associated with endocrine resistance in breast cancer
    Fleming, F
    Hill, A
    Mc Dermott, E
    O'Higgins, N
    Young, L
    [J]. BRITISH JOURNAL OF CANCER, 2003, 88 : S14 - S14
  • [4] Inverse relationship between ER-β and SRC-1 predicts outcome in endocrine-resistant breast cancer
    E Myers
    F J Fleming
    T B Crotty
    G Kelly
    E W McDermott
    N J O'Higgins
    A D K Hill
    L S Young
    [J]. British Journal of Cancer, 2004, 91 : 1687 - 1693
  • [5] Inverse relationship between ER-β and SRC-1 predicts outcome in endocrine-resistant breast cancer
    Myers, E
    Fleming, FJ
    Crotty, TB
    Kelly, G
    McDermott, EW
    O'Higgins, NJ
    Hill, ADK
    Young, LS
    [J]. BRITISH JOURNAL OF CANCER, 2004, 91 (09) : 1687 - 1693
  • [6] Global characterisation of the SRC-1 transciptome identifies disintegrin C as an ER-independent mediator of endocrine resistant breast cancer
    Bolger, J. C.
    McCartan, D. P.
    McIlroy, M.
    Byrne, C.
    Fagan, A.
    Xu, J.
    O'Gaora, P.
    Hill, A. D. K.
    Young, L. S.
    [J]. BRITISH JOURNAL OF SURGERY, 2012, 99 : 2 - 2
  • [7] Global characterization of the SRC-1 transcriptome identifies ADAM22 as an ER-independent mediator of endocrine resistant breast cancer
    Bolger, J. C.
    McCartan, D. P.
    McIlroy, M.
    Byrne, C.
    Fagan, A.
    Xu, J.
    O'Gaora, P.
    Hill, A. D. K.
    Young, L. S.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2012, 181 : 20 - 20
  • [8] Global Characterization of the SRC-1 Transcriptome Identifies Disintegrin C as an ER-Independent Mediator of Endocrine Resistant Breast Cancer.
    Bolger, J. C.
    McCaftan, D. P.
    Mcllroy, M.
    Byrne, C.
    Fagan, A.
    Xu, J.
    O'Gaora, P.
    Hill, A. D. K.
    Young, L. S.
    [J]. CANCER RESEARCH, 2011, 71
  • [9] Global Characterization of the SRC-1 Transcriptome Identifies ADAM22 as an ER-Independent Mediator of Endocrine-Resistant Breast Cancer
    McCartan, Damian
    Bolger, Jarlath C.
    Fagan, Ailis
    Byrne, Christopher
    Hao, Yuan
    Qin, Li
    McIlroy, Marie
    Xu, Jianming
    Hill, Arnold D.
    Gaora, Peadar O.
    Young, Leonie S.
    [J]. CANCER RESEARCH, 2012, 72 (01) : 220 - 229
  • [10] Ets-2 and p160 proteins collaborate to regulate c-Myc in endocrine resistant breast cancer
    D Al-azawi
    M Mc Ilroy
    G Kelly
    A M Redmond
    F T Bane
    S Cocchiglia
    A D K Hill
    L S Young
    [J]. Oncogene, 2008, 27 : 3021 - 3031
123